From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
JAMA Editors' Summary
00:00
GLP-1s and Heart Failure Outcomes
Kirsten explains the clinical-trial-emulation showing semaglutide/trezepatide linked to lower HFpEF hospitalization and mortality.
Play episode from 04:07
Transcript
